Generate Biomedicines, Inc. GENB Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q1 '25 | ||
|---|---|---|---|---|
| $160.58M+32.0% | $121.65M-44.9% | $220.61M— | ||
| $356.07M+257% | $99.85M— | —— | ||
| $535.39M+128% | $234.37M— | —— | ||
| $27.84M-4.5% | $29.15M— | —— | ||
| $625.74M+89.5% | $330.18M— | —— | ||
| $7.62M+98.5% | $3.84M+743% | -$597K— | ||
| $58.39M-29.0% | $82.2M— | —— | ||
| $110.94M-21.6% | $141.55M— | —— | ||
| -$737.74M-9.1% | -$676.29M— | —— | ||
| $514.8M+184% | -$615.97M-30.8% | -$471M-8.4% | ||
| $625.74M+89.5% | $330.18M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Generate Biomedicines, Inc. 's total assets?
- Generate Biomedicines, Inc. (GENB) holds $625.7M in total assets.
- How much debt does Generate Biomedicines, Inc. have?
- Generate Biomedicines, Inc. carries $65.6M in total debt against $514.8M of shareholders' equity, a debt-to-equity ratio of 0.13.
- How much cash does Generate Biomedicines, Inc. have?
- Generate Biomedicines, Inc. holds $160.6M in cash and equivalents.
- Can Generate Biomedicines, Inc. cover its short-term obligations?
- Its current ratio is 9.17 — current assets exceed current liabilities.
- Where does Generate Biomedicines, Inc. 's balance sheet data come from?
- Every line is extracted from Generate Biomedicines, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.